Signals
Europe is building the infrastructure to decide which cardiovascular AI can be trusted
The European Society of Cardiology is leading a new €20 million EU4Health initiative designed to move cardiovascular AI from fragmented pilots into validated, scalable clinical use. CHAIN will connect hospitals, registries and health-data infrastructures across Europe, test six real-world use cases in 13 countries and create “AI passports” documenting performance, safety and clinical suitability.
Avexitide Phase 3 trial cuts post-bariatric hypoglycemia events by 55%
Borderline blood pressure is not harmless. The mistakes that let cardiovascular risk build quietly
A sweat patch can continuously track cholesterol and triglycerides. Blood tests are not obsolete yet
Progressive MS Still Needs Repair, Not Relapse Logic
Pregnancy Is Now an ADHD Care Gap
Parkinson’s Gets Fast Track, Not Fast Proof
Anxiety Gets a Psychedelic Trial, Not a Shortcut
Antidepressant Trials Still Leave People Out
The first oral PCSK9 inhibitor is approved. A pill will not fix cholesterol access by itself
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.